Dietary and lifestyle habits among individuals living with chronic pain.
BIO, PhRMA, others seek tweaks to FDA draft guidance on diversity in postmarketing studies
After the FDA published draft guidance over the summer on postmarketing approaches to collecting data from underrepresented groups, stakeholder groups largely welcomed the FDA’s proposals